Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.8 USD | +1.59% |
|
-0.01% | +6.17% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.17% | 164B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
-0.45% | 162B | |
-.--% | 122B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Sector Update: Health Care